Pharmaceuticals news and pharmaceuticals widget
Sunday, November 16, 2008 ( change date )
Novexel?s NXL104/ceftazidime Combination Commences Phase II Clinical Trial
Novexe announced that its most advanced injectable antibacterial, which combines Novexel?s broad spectrum beta-lactamase inhibitor, NXL104, with the well established cephalosporin antibiotic, ...
bionity.com Sunday, November 16, 2008
PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET